171 related articles for article (PubMed ID: 34011352)
1. Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans.
Schwarm C; Gola D; Holtsche MM; Dieterich A; Bhandari A; Freitag M; Nürnberg P; Toliat M; Lieb W; Wittig M; Franke A; Worm M; Sticherling M; Ehrchen J; Günther C; Gläser R; Peitsch WK; Sárdy M; Eming R; Hertl M; Benoit S; Goebeler M; Pföhler C; Kunz M; Kreuter A; van Beek N; Erdmann J; Busch H; Zillikens D; Sadik CD; Hirose M; König IR; Schmidt E; Ibrahim SM;
Orphanet J Rare Dis; 2021 May; 16(1):228. PubMed ID: 34011352
[TBL] [Abstract][Full Text] [Related]
2. A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
Amber KT; Zikry J; Hertl M
HLA; 2017 Mar; 89(3):127-134. PubMed ID: 28101965
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans.
Russlies J; Fähnrich A; Witte M; Yin J; Benoit S; Gläser R; Günter C; Eming R; Erdmann J; Gola D; Gupta Y; Holtsche MM; Kern JS; König IR; Kiritsi D; Lieb W; Sadik CD; Sárdy M; Schauer F; van Beek N; Weidinger A; Worm M; Zillikens D; Schmidt E; Busch H; Ibrahim SM; Hirose M
Front Immunol; 2019; 10():2200. PubMed ID: 31824475
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.
Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E
J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics.
Nishie W
Immunol Med; 2019 Mar; 42(1):22-28. PubMed ID: 31169082
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
7. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid and milia: prevalence and clinical laboratory findings in a Brazilian sample.
Vernal S; Oliveira EV; Bueno Filho R; Julio TA; Donadi EA; Turatti A; Ishii N; Hashimoto T; Roselino AM
An Bras Dermatol; 2022; 97(4):435-442. PubMed ID: 35637051
[TBL] [Abstract][Full Text] [Related]
9. Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders.
Sernicola A; Mazzetto R; Tartaglia J; Ciolfi C; Miceli P; Alaibac M
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003999
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
[TBL] [Abstract][Full Text] [Related]
11. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
Mai Y; Nishie W; Izumi K; Shimizu H
Front Immunol; 2019; 10():1224. PubMed ID: 31191560
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid.
Okazaki A; Miyagawa S; Yamashina Y; Kitamura W; Shirai T
J Dermatol; 2000 Mar; 27(3):149-56. PubMed ID: 10774139
[TBL] [Abstract][Full Text] [Related]
14. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
van Beek N; Schulze FS; Zillikens D; Schmidt E
Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
[TBL] [Abstract][Full Text] [Related]
15. Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid.
Rosi-Schumacher M; Baker J; Waris J; Seiffert-Sinha K; Sinha AA
Front Immunol; 2023; 14():1159351. PubMed ID: 37180132
[TBL] [Abstract][Full Text] [Related]
16. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR and DQ polymorphisms in bullous pemphigoid from northern China.
Gao XH; Winsey S; Li G; Barnardo M; Zhu XJ; Chen HD; Song F; Zhai N; Fuggle S; Wojnarowska F
Clin Exp Dermatol; 2002 Jun; 27(4):319-21. PubMed ID: 12139680
[TBL] [Abstract][Full Text] [Related]
18. Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
Khdair SI; Jarrar W; Jarrar YB; Bataineh S; Al-Khaldi O
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):895-902. PubMed ID: 31742498
[TBL] [Abstract][Full Text] [Related]
19. Role of BP230 autoantibodies in bullous pemphigoid.
Shih YC; Wang B; Yuan H; Zheng J; Pan M
J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
[TBL] [Abstract][Full Text] [Related]
20. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E;
Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]